论文部分内容阅读
目前普遍承认长期抗凝疗法对血栓栓塞患者十分重要,它可降低肺栓塞的复发率。对肺栓塞和深部静脉血栓形成的患者,惯用香豆素一类的抗凝药,如丙酮苄羟香豆素(华法令)。虽已反复证实它能有效的预防血栓栓塞的复发,但有造成出血性合并症的危险,并具有高敏感反应、胃肠不适和皮肤坏死等付作用。本文试图用肝素小剂量皮下注射疗法代替华法令,以防治肺栓塞和大退深部静脉血栓形成。受试者48名;肺栓塞占21名,大腿深部静脉血栓形成占27名。全部患者先用静脉注射肝
Long-term anticoagulant therapy is currently widely recognized in patients with thromboembolism is very important, it can reduce the recurrence rate of pulmonary embolism. In patients with pulmonary embolism and deep venous thrombosis, the usual coumarin-class anticoagulants, such as acetone benzyl coumarin (warfarin). Although it has repeatedly confirmed that it can effectively prevent the recurrence of thromboembolism, but there is the risk of bleeding complications, and has high sensitivity, gastrointestinal discomfort and skin necrosis and other pay. This article attempts to use low-dose heparin subcutaneous injection therapy instead of warfarin to prevent pulmonary embolism and deep retreat deep venous thrombosis. Subjects 48; pulmonary embolism accounted for 21, thigh deep vein thrombosis accounted for 27. All patients first intravenous injection of liver